GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Galderma Group AG (XSWX:GALD) » Definitions » Other Current Payables

Galderma Group AG (XSWX:GALD) Other Current Payables : CHF55 Mil (As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Galderma Group AG Other Current Payables?

Galderma Group AG's Other Current Payables for the quarter that ended in Dec. 2024 was CHF55 Mil.

Galderma Group AG's quarterly Other Current Payables declined from Dec. 2023 (CHF51 Mil) to Jun. 2024 (CHF0 Mil) but then increased from Jun. 2024 (CHF0 Mil) to Dec. 2024 (CHF55 Mil).

Galderma Group AG's annual Other Current Payables increased from . 20 (CHF0 Mil) to Dec. 2023 (CHF51 Mil) and increased from Dec. 2023 (CHF51 Mil) to Dec. 2024 (CHF55 Mil).

Galderma Group AG Other Current Payables Historical Data

The historical data trend for Galderma Group AG's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Galderma Group AG Other Current Payables Chart

Galderma Group AG Annual Data
Trend Dec23 Dec24
Other Current Payables
51.02 55.28

Galderma Group AG Semi-Annual Data
Jun23 Dec23 Jun24 Dec24
Other Current Payables - 51.02 - 55.28

Galderma Group AG Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Galderma Group AG Other Current Payables Related Terms

Thank you for viewing the detailed overview of Galderma Group AG's Other Current Payables provided by GuruFocus.com. Please click on the following links to see related term pages.

Galderma Group AG Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Galderma Group AG (XSWX:GALD) » Definitions » Other Current Payables
Comparable Companies
XSWX:SDZ XSWX:SFZN XSWX:PPGN XSWX:CURN ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN HKSE:03692 NSE:DIVISLAB XTAE:TEVA SHSE:688506 TSE:4507 BOM:500087 SZSE:000538 NSE:TORNTPHARM UTHR BOM:500124 NBIX
Traded in Other Exchanges
GALDY:USA GDERF:USA GALDz:UK PY3:Germany
Address
Zahlerweg 10, Zug, CHE, 6300
Website
https://www.galderma.com
Galderma was formed in 1981 as a joint venture between Nestle and L'Oreal. It subsequently became a subsidiary of Nestle, called Nestle Skin Health, before being carved out and launched as a standalone company in 2019, acquired by a consortium led by Sweden-based EQT fund. The company went public in March 2024 and is listed on the SIX Swiss exchange. Galderma's science-based portfolio spans multiple dermatology categories, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. It derives around 45% of net sales from the US and employs around 6,600 people.

Galderma Group AG Headlines

No Headlines